(f) Any Equity Cure must be made in cash and no more than three (3) Equity Cures are to be made over the life of the Bonds. Equity Cures may not be injected in respect of any consecutive calendar quarters.
13.1 General
The Issuer undertakes to (and shall, where applicable, procure that each other Group Company will) comply with the undertakings set out in this Clause 13 for as long as any Bonds remain outstanding.
13.2 Distributions
The Issuer shall not, and shall procure that none of the Subsidiaries (other than to the Issuer or a wholly owned subsidiary of the Issuer), (i) pay any dividend in respect of its shares (ii) repurchase or redeem any of its own shares, (iii) redeem or reduce its share capital or other restricted or unrestricted equity with repayment to shareholders, (iv) repay any shareholder loans or pay interest thereon, (v) make any prepayments or repayments under any long-term debt subordinated to the Bonds, (vi) grant any loans except to Group Companies, or (vii) make any other similar distribution or transfers of value to the Issuer's, or the Subsidiaries', direct and indirect shareholders or the Affiliates of such direct and indirect shareholders (other than to the Issuer or any wholly owned Subsidiary of the Issuer) (items (i)-(vii) above are together and individually referred to as a "Restricted Payment").
24
13.3 Nature of Business
The Issuer shall procure that no substantial change is made to the general nature of the business carried on by the Group as of the First Issue Date if such substantial change would have a Material Adverse Effect.
13.4 Financial Indebtedness
